GVR Report cover Endoscopic Retrograde Cholangiopancreatography Market Size, Share & Trends Report

Endoscopic Retrograde Cholangiopancreatography Market Size, Share & Trends Analysis Report By Product (Endoscopes, Endotherapy Devices), By Procedure (Biliary Sphincterotomy, Pancreatic Sphincterotomy), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-4-68040-327-5
  • Number of Report Pages: 120
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2023
  • Forecast Period: 2024 - 2030 
  • Industry: Healthcare

Market Size & Trends

The global endoscopic retrograde cholangiopancreatography market size was estimated at USD 1.98 billion in 2023 and is anticipated to grow at a CAGR of 8.3% from 2024 to 2030. This growth is majorly driven by the rising incidence of pancreatic and biliary diseases such as gallstones, pancreatitis, and bile duct obstructions fueling the demand for endoscopic retrograde cholangiopancreatography (ERCP) procedures. As the population ages and lifestyles change, the prevalence of these conditions is expected to increase, driving market growth. According to the Clinical Gastroenterology and Hepatology study published in February 2024, there is an estimated 6% prevalence of gallstones globally, with higher rates observed in females and South America. According to studies, the incidence rate of gallstones is anticipated to rise sharply over the forecast period, thereby driving the demand for ERCP procedures.

Endoscopic Retrograde Cholangiopancreatography Market size and growth rate, 2024 - 2030

Furthermore, advancements in endoscopic technology have improved the safety and efficacy of ERCP procedures. For instance, in January 2023, Advantech introduced the MIO-5377R single-board computer as a groundbreaking innovation in the field of endoscope technology. This compact and powerful device is designed to address the traditional challenges faced by endoscopes, offering enhanced performance, reliability, and functionality. Moreover, innovations such as high-definition imaging, better maneuverability of endoscopes, and the development of therapeutic accessories have made ERCP a more precise and effective diagnostic and treatment tool. These technological advancements are attracting both healthcare providers and patients to opt for ERCP procedures.

The rise in the adoption of minimally invasive surgical techniques has led to an increased demand for ERCP procedures, which is expected to drive growth in the industry in the upcoming years. For instance, according to the American Cancer Society's annual report published in January 2024, an estimated 41,630 new cases of liver cancer are expected to be diagnosed in the U.S. Additionally, as per the same source, liver cancer is more prevalent in countries in sub- Southeast Asia and Saharan Africa compared to the U.S. It is the most common type of cancer in many of these nations, with over 800,000 new cases diagnosed globally each year. Additionally, liver cancer ranks as a leading cause of cancer-related deaths worldwide, claiming more than 700,000 lives annually.

The Most Common Types of Liver Cancer Globally (%)

The high burden of cholangiocarcinoma and hepatocellular carcinoma is expected to boost the demand for endoscopic retrograde cholangiopancreatography for the early detection of such malignancies.

Moreover, the increased awareness about the benefits of early diagnosis and treatment of pancreatic and biliary diseases has led to a higher demand for minimally invasive procedures such as ERCP. For instance, in October 2023. the Biliary Atresia Awareness Committee launched Biliary Atresia Awareness Campaign under the auspices of Gauteng Provincial Solid Organ Transplant Division and the University of the Witwatersrand at Charlotte Maxeke Academic Hospital. The campaign was aimed to raise awareness and support for children affected by biliary atresia, a rare and life-threatening liver disease that affects infants by obstructing or obliterating bile ducts. The initiative was focused on educating diverse demographics about biliary atresia, offering resources and support to affected families, advancing research for diagnostic tools and treatments, and fostering collaboration with medical entities globally.

The aging population is a significant factor driving the growth of the ERCP market. As the global population continues to age, there is a growing demand for these procedures, including surgeries that require blood transfusions. Chronic diseases such as caugulopathy, anemia, and surgical blood seeking continue to increase along with the increase in adult population. Currently, there are over 40 million people in the U.S. alone above 65 years and the number are expected to double by 2050. Japan provides potential growth opportunities to this market due to the presence of the highest geriatric population in the globe. According to WHO, the percentage of the geriatric population is expected to reach 22.0% by 2050.

Additionally, several healthcare organizations are adopting initiatives including partnerships for the R&D of innovative products, thereby fueling the market growth. For instance, according to research study published in Optica Publishing Group journal in July 2022, researchers at the School of Biomedical Engineering & Imaging Sciences developed a photoacoustic imaging endoscope probe which can be inserted into a medical needle with an inner diameter as small as 0.6 millimeters. They also suggested that artificial intelligence (AI) could be utilized to accelerate imaging procedures.

Furthermore, the strategic initiatives adopted by the market players, such as mergers, and acquisitions, and product launches are projected to drive the market over the forecast period. For instance, in April 2022, Olympus partnered with EndoClot Plus, a company that focuses on developing technologies in the hemostasis space. One of the key products in EndoClot Plus’ portfolio is the EndoClot PHS, a nonthermal, nontraumatic method for achieving hemostasis with gastrointestinal (GI) bleeds. This agreement aims to make the EndoClot PHS more accessible to gastroenterologists, enabling them to stop bleeding rapidly and reliably during medical procedures.

Product Insights

The endotherapy devices segment accounted for the largest market share of 37.6% in 2023. The growth is attributed to its the less invasive properties and affordable post and pre-procedure cost of endoscopy devices are the major factors anticipated to boost the market growth over the forecast period. For instance, wireless capsule endoscopy (WCE) is a cutting-edge medical technology that revolutionizes the way gastrointestinal disorders are diagnosed and monitored. One of the primary advantages of WCE is its non-invasive nature. Unlike traditional endoscopic procedures that require sedation and insertion of a flexible tube through the mouth or rectum, WCE involves swallowing a capsule, eliminating discomfort and risks associated with invasive techniques.

Furthermore, a shift in trend to use disposable endoscopic components to minimize the procedure cost as well as the chance of cross-contamination is also expected to accelerate market growth over the years. In addition, the development and adoption of endoscopic techniques such as uniportal full endoscopic posterolateral transforaminal lumbar interbody fusion (Endo-TLIF) have been driven by the desire to reduce operative time, blood loss, postoperative pain, and complications related to extensive tissue disruption in traditional procedures.

The endoscopes segment is expected to grow at the fastest CAGR during the forecast period. Technological advancements have significantly impacted the field of endoscopes, which is expected to drive innovation and improve patient care. These advancements have led to the development of more advanced & sophisticated disposable endoscopes, offering enhanced imaging capabilities, improved maneuverability, and ease of use. For instance, integrating high-definition cameras and advanced optics has resulted in sharper and clearer images, aiding in accurate diagnosis and treatment. The miniaturization of components has created smaller and more flexible endoscopes, enabling easier access to narrow & complex anatomical structures.

Innovations such as chip-in-tip and chip-in-scope technologies have led to lightweight, efficient endoscopic systems that do not require separate light sources. The introduction of robotic-assisted systems, such as the Intuitive Surgical da Vinci, has revolutionized minimally invasive surgeries by offering precise 3D imaging and enhanced dexterity.

Procedure Insights

The biliary sphincterotomy segment accounted for the largest market share in 2023. The growth is owed to the several benefits offered by this procedure which include relief of symptoms, management of complications, and improvement in quality of life. Patients with gallstones or other obstructions in the bile ducts may experience symptoms such as abdominal pain, jaundice, nausea, and vomiting. These symptoms can be alleviated by allowing better drainage of bile from the liver and gallbladder by performing a biliary sphincterotomy. Additionally, this procedure can help manage complications including cholangitis (infection of the bile ducts) or pancreatitis (inflammation of the pancreas), which can arise from blocked bile flow.

The pancreatic sphincterotomy segment is expected to grow at the fastest CAGR during the forecast period. The growth is owed to the need for a pancreatic sphincterotomy to alleviate symptoms and improve the flow of digestive enzymes and bile from the pancreas into the small intestine. This procedure helps to relieve pain, reduce inflammation, prevent complications such as pancreatitis, and improve overall pancreatic function. Patients with recurrent episodes of pancreatitis or those with obstructive pancreatic ductal diseases may benefit from this intervention to enhance their quality of life and prevent further complications.

End-use Insights

The outpatient facilities segment accounted for the largest market share in 2023 and is anticipated to grow at a fastest CAGR of 9.1% over the forecast period. The growing use of endoscopes in outpatient centers, such as diagnostic clinics and ambulatory surgery centers (ASCs), is likely to promote segment growth by enabling early diagnosis and detection of chronic conditions. These outpatient centers offer effective diagnostic and therapeutic options.

Endoscopic Retrograde Cholangiopancreatography Market share and size, 2023

The rising demand for endoscopes in these settings is increasing due to their multiple benefits. A key benefit in these outpatient environments is the cost-efficiency. Using disposable endoscopes eliminates the need for time-consuming reprocessing activities, including cleaning, sterilizing, and maintaining reusable endoscopes. This efficiency enhances workflow and patient throughput, accelerating market growth.

Regional Insights

North America dominated the market with a revenue share of 41.0% in 2023. The high prevalence of several diseases, such as gastrointestinal disorders, respiratory conditions, urological problems, gynecological issues, and cancer, is increasing the need for endoscopic procedures for diagnosis & treatment in North America. For instance, according to a report by ResearchGate, it is projected that there will be 2,001,140 new cases of cancer and 611,720 cancer-related deaths in the U.S. in 2024.

Hence, the growing need for accurate and minimally invasive diagnostic tools is driving the adoption of endoscopes. Moreover, the market is also fueled by rapid technological advancements, leading to the development of new and innovative endoscopic devices. These technological breakthroughs have improved the adoption of endoscopes. For instance, in October 2022, OMNIVISION, a prominent developer of semiconductor solutions, collaborated with AdaptivEndo, a technology disruptor in single-use endoscopes, to create a flexible and unified platform.

U.S. Endoscopic Retrograde Cholangiopancreatography Market Trends

U.S. endoscopic retrograde cholangiopancreatography marketheld the largest share in 2023, in the North American region. The rising demand for disposable endoscopes due to the growing burden of bacterial infections transmitted through contaminated endoscopes in hospitals is positively impacting the endoscopes market growth. Furthermore, many industry players in the U.S. initially pursued approval from the FDA to introduce their products in the country, promoting market growth. Moreover, increasing awareness of cost-effective single-use endoscopes and the high per capita health expenditure are contributing to market growth in the country.

Europe Endoscopic Retrograde Cholangiopancreatography Market Trends

The endoscopic retrograde cholangiopancreatography market in Europe is expected to witness lucrative growth over the forecast period. The ongoing technological advancements in endoscopy, increase in the geriatric population, and rise in demand for minimally invasive procedures are among the factors driving the European market. Favorable macro environment factors are driving key players to revise their market entry strategies through mergers & acquisitions and technological collaborations to expand their footprint. For instance, in January 2021, Olympus Corporation signed an agreement to acquire Quest Photonic Devices B.V. for USD 60.18 million (EUR 50 million). Quest Photonic Devices B.V., a company based in the Netherlands, offers Fluorescence Imaging Systems (FIS) for open and minimally invasive procedures.

Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market Trends

Asia Pacific (APAC) is anticipated to be the fastest-growing region owing to the improved healthcare infrastructure, the presence of a less stringent regulatory framework, and economic development attracting foreign investments. Key market players are developing strategies for expanding their business in this region. Growth in the region is expected to be driven by favorable initiatives undertaken by private players, such as training healthcare professionals and increasing Research & Development (R&D) investments to develop advanced endoscopes. For instance, Olympus Corporation opened a Thai Training and Education Centre, to increase awareness about surgical & Gastrointestinal (GI) endoscopes and provide training to healthcare professionals in Southeast Asia.

Key Endoscopic Retrograde Cholangiopancreatography Company Insights

The market is a dynamic and competitive industry with several key players vying for market share. The companies in this market are focusing on research and development, along with strategic partnerships and product launches. The commitment to advancing care through technological innovations has contributed to substantial market share.

Key Endoscopic Retrograde Cholangiopancreatography Companies:

The following are the leading companies in the endoscopic retrograde cholangiopancreatography market. These companies collectively hold the largest market share and dictate industry trends.

  • Olympus Corporation
  • CONMED Corporation
  • Boston Scientific Corporation
  • Medtronic PLC
  • Telemed System, Inc.
  • AMBU, Inc.
  • FUJIFILM Holdings Corporation
  • Hobbs Medical, Inc.
  • Cook Group
  • Streis PLC
  • HOYA Group
  • Karl Storz SE & Co. KG

Recent Developments

  • In March 2024, NTT Corporation (NTT) and Olympus Corporation embarked on a joint venture to conduct a demonstration experiment of a cloud endoscopy system. This innovative system facilitates image processing through cloud computing, marking a significant advancement in the field of medical technology. The collaboration between NTT and Olympus to develop a cloud endoscopy system represents a groundbreaking development in the field of medical imaging.

  • In November 2023, HOYA Corporation acquired the remaining shares of WASSENBURG Medical B.V. This acquisition made HOYA the sole shareholder of WASSENBURG and strengthened its position in the medical equipment industry, particularly in endoscope reprocessing. The combined capabilities of HOYA Corporation, PENTAX Medical, and WASSENBURG Medical are likely to drive advancements in endoscope reprocessing technology & services. This collaboration could result in improved efficiency, safety, and quality standards in healthcare facilities worldwide that rely on endoscopic procedures.

  • In January 2024, Canon Medical Systems Corporation and Olympus Corporation announced a collaboration agreement to work together on endoscopic ultrasound systems. In this partnership, Canon Medical is expected to be responsible for developing and manufacturing diagnostic ultrasound systems specifically designed for Endoscopic Ultrasonography (EUS).

Endoscopic Retrograde Cholangiopancreatography Market Report Scope

Report Attribute


Market size value in 2024

USD 2.17 billion

Revenue forecast in 2030

USD 3.51 billion

Growth rate

CAGR of 8.3% from 2024 to 2030

Historical data

2018 - 2023

Forecast data

2024 - 2030

Quantitative units

Revenue in USD million/billion and CAGR from 2024 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, procedure, end-use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Sweden; Denmark; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait

Key companies profiled

Olympus Corporation; CONMED Corporation; Boston Scientific Corporation; Medtronic PLC; Telemed System, Inc.; AMBU, Inc.; FUJIFILM Holdings Corporation; Hobbs Medical, Inc.; Cook Group; Streis PLC; HOYA Group; Karl Storz SE & Co. KG

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Global Endoscopic Retrograde Cholangiopancreatography Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global endoscopic retrograde cholangiopancreatography market report based on product, procedure, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)

    • Endoscopes

    • Endotherapy Devices

      • Sphincterotomes

      • Lithotripter

      • Stents

      • Cannulas

      • Forceps

      • Snares

      • Catheters

      • Guiding Wires

      • Balloons

      • Baskets

    • Visualization Systems

    • Energy Devices

    • Others

  • Procedure Outlook (Revenue, USD Million, 2018 - 2030)

    • Biliary Sphincterotomy

    • Biliary Stenting

    • Biliary Dilatation

    • Pancreatic Sphincterotomy

    • Pancreatic Duct Stenting

    • Pancreatic Duct Dilation

  • End use Outlook (Revenue, USD Million, 2018 - 2030)

    • Hospitals

    • Outpatient Facilities

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Norway

      • Sweden

      • Denmark

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

      • Thailand

    • Latin America

      • Brazil

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.